HUP0303758A3 - Heterocyclylalkyl piperidine derivatives and their preparation and pharmaceutical compositions containing them - Google Patents

Heterocyclylalkyl piperidine derivatives and their preparation and pharmaceutical compositions containing them

Info

Publication number
HUP0303758A3
HUP0303758A3 HU0303758A HUP0303758A HUP0303758A3 HU P0303758 A3 HUP0303758 A3 HU P0303758A3 HU 0303758 A HU0303758 A HU 0303758A HU P0303758 A HUP0303758 A HU P0303758A HU P0303758 A3 HUP0303758 A3 HU P0303758A3
Authority
HU
Hungary
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
piperidine derivatives
heterocyclylalkyl piperidine
Prior art date
Application number
HU0303758A
Other languages
English (en)
Original Assignee
Novexel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novexel filed Critical Novexel
Publication of HUP0303758A2 publication Critical patent/HUP0303758A2/hu
Publication of HUP0303758A3 publication Critical patent/HUP0303758A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
HU0303758A 2000-11-15 2001-11-14 Heterocyclylalkyl piperidine derivatives and their preparation and pharmaceutical compositions containing them HUP0303758A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0014738A FR2816618B1 (fr) 2000-11-15 2000-11-15 Derives heterocyclylalcoyl piperidine, leur preparation et les compositions qui les contiennent
PCT/FR2001/003559 WO2002040474A2 (fr) 2000-11-15 2001-11-14 Derives heterocyclylalcoyl piperidine et leur application comme antimicrobiens

Publications (2)

Publication Number Publication Date
HUP0303758A2 HUP0303758A2 (hu) 2004-03-01
HUP0303758A3 true HUP0303758A3 (en) 2009-08-28

Family

ID=8856503

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0303758A HUP0303758A3 (en) 2000-11-15 2001-11-14 Heterocyclylalkyl piperidine derivatives and their preparation and pharmaceutical compositions containing them

Country Status (28)

Country Link
EP (2) EP1337529B1 (hu)
JP (1) JP2004514661A (hu)
KR (1) KR100849608B1 (hu)
CN (1) CN1483031A (hu)
AR (1) AR034006A1 (hu)
AT (1) ATE337311T1 (hu)
AU (2) AU1836502A (hu)
BG (1) BG107793A (hu)
BR (1) BR0115312A (hu)
CA (1) CA2429311A1 (hu)
CZ (1) CZ20031316A3 (hu)
DE (1) DE60122567T2 (hu)
DK (1) DK1337529T3 (hu)
EA (1) EA200300568A1 (hu)
EE (1) EE200300207A (hu)
ES (1) ES2271119T3 (hu)
FR (1) FR2816618B1 (hu)
HR (1) HRP20030379A2 (hu)
HU (1) HUP0303758A3 (hu)
IL (1) IL155841A0 (hu)
NO (2) NO20032187L (hu)
PL (1) PL363004A1 (hu)
PT (1) PT1337529E (hu)
SK (1) SK5822003A3 (hu)
TN (1) TNSN01160A1 (hu)
WO (1) WO2002040474A2 (hu)
YU (1) YU46803A (hu)
ZA (1) ZA200303794B (hu)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL366335A1 (en) 2000-07-26 2005-01-24 Smithkline Beecham P.L.C. Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
GB0101577D0 (en) 2001-01-22 2001-03-07 Smithkline Beecham Plc Compounds
GB0112836D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
GB0112834D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
GB0118238D0 (en) * 2001-07-26 2001-09-19 Smithkline Beecham Plc Medicaments
EP1470131A2 (en) 2002-01-29 2004-10-27 Glaxo Group Limited Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them
US7312212B2 (en) 2002-01-29 2007-12-25 Glaxo Group Limited Aminopiperidine derivatives
TW200406413A (en) 2002-06-26 2004-05-01 Glaxo Group Ltd Compounds
TW200409637A (en) 2002-06-26 2004-06-16 Glaxo Group Ltd Compounds
FR2842807A1 (fr) * 2002-07-23 2004-01-30 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, procede et intermediaires de preparation et compositions les renfermant
GB0217294D0 (en) * 2002-07-25 2002-09-04 Glaxo Group Ltd Medicaments
FR2844268B1 (fr) * 2002-09-11 2004-10-22 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leurs procedes et intermediaires de preparation et les compositions qui les contiennent
FR2844270B1 (fr) * 2002-09-11 2006-05-19 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leur procede et intermediaires de preparation et les compositions qui les contiennent
DE10256405A1 (de) * 2002-12-02 2004-06-17 Morphochem Aktiengesellschaft für kombinatorische Chemie Neue Verbindungen, die Topoisomerase IV inhibieren
ES2340484T3 (es) 2002-11-05 2010-06-04 Glaxo Group Limited Agentes antibacterianos.
EP1567520B1 (en) 2002-12-04 2008-10-15 Glaxo Group Limited Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents
US7232833B2 (en) 2003-03-28 2007-06-19 Novexel 4-substituted quinoline derivatives, method and intermediates for their preparation and pharmaceutical compositions containing them
FR2852954B1 (fr) * 2003-03-28 2006-07-14 Aventis Pharma Sa Derives de quinoleines-4-substituees, leurs procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent
FR2862301B1 (fr) * 2003-11-17 2007-12-21 Aventis Pharma Sa Nouveau procede de preparation de quinoleines 3-fluorees
FR2867472B1 (fr) * 2004-03-12 2008-07-18 Aventis Pharma Sa Derives de quinoleines-4-substituees, leurs procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent
WO2006081182A2 (en) 2005-01-25 2006-08-03 Glaxo Group Limited Antibacterial agents
US7605169B2 (en) 2005-01-25 2009-10-20 Glaxo Group Limited Antibacterial agents
JP2008528586A (ja) 2005-01-25 2008-07-31 グラクソ グループ リミテッド 抗菌剤
EP1845995A4 (en) 2005-01-25 2010-03-03 Glaxo Group Ltd ANTIBACTERIAL AGENTS
CN101166730A (zh) 2005-03-01 2008-04-23 惠氏公司 噌啉化合物及其作为肝x受体调节剂的用途
MY150958A (en) 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
ES2376488T3 (es) 2006-01-26 2012-03-14 Actelion Pharmaceuticals Ltd. Antibióticos de tetrahidropirano.
ATE481406T1 (de) 2006-04-06 2010-10-15 Glaxo Group Ltd Pyrrolochinoxalinonderivate als antibakterielle mittel
EP1992628A1 (en) 2007-05-18 2008-11-19 Glaxo Group Limited Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
AR067008A1 (es) 2007-06-15 2009-09-30 Actelion Pharmaceuticals Ltd Derivados 3- amino-6-(1- amino - etil)-tetrahidropirano
EP2080761A1 (en) 2008-01-18 2009-07-22 Glaxo Group Limited Compounds
JP2012505866A (ja) 2008-10-17 2012-03-08 グラクソ グループ リミテッド 抗菌剤として使用される三環式窒素化合物
WO2010081874A1 (en) 2009-01-15 2010-07-22 Glaxo Group Limited Naphthyridin-2 (1 h)-one compounds useful as antibacterials
CN107163038B (zh) * 2012-08-15 2020-07-28 葛兰素集团有限公司 化学方法
SG11201700566SA (en) 2014-08-22 2017-03-30 Glaxosmithkline Ip Dev Ltd Tricyclic nitrogen containing compounds for treating neisseria gonorrhoea infection
WO2016138988A1 (en) * 2015-03-02 2016-09-09 University Of Copenhagen Piperazine inhibitors of bacterial gyrase and topoisomerase iv
UY36851A (es) 2015-08-16 2017-03-31 Glaxosmithkline Ip Dev Ltd Compuestos para uso en aplicaciones antibacterianas

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7908031A (nl) 1979-11-01 1981-06-01 Acf Chemiefarma Nv Nieuwe chinolinederivaten en farmaceutische preparaten die een dergelijke verbinding bevatten, alsmede werk- wijze voor het bereiden van deze verbindingen.
JPH0239546A (ja) 1988-07-29 1990-02-08 Origin Electric Co Ltd 混成集積回路の製造方法
NZ232091A (en) 1989-01-16 1990-12-21 Bellon Labor Sa Roger 7-fluoro-8-(piperazin-1-yl)-4-oxo-1,4-dihydro-benzo(b)(1,8)naphthyridine-3-carboxylic acid derivatives, preparation and pharmaceutical compositions thereof
DE69908555T2 (de) * 1998-01-26 2004-05-06 Smithkline Beecham P.L.C., Brentford Chinolinderivate als antibakterielles arzneimittel
AU2437900A (en) * 1999-01-20 2000-08-07 Smithkline Beecham Plc Piperidinylquinolines as protein tyrosine kinase inhibitors
FR2852954B1 (fr) * 2003-03-28 2006-07-14 Aventis Pharma Sa Derives de quinoleines-4-substituees, leurs procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
NO20072142L (no) 2007-04-25
AU2002218365B2 (en) 2007-07-05
TNSN01160A1 (fr) 2005-11-10
EP1337529B1 (fr) 2006-08-23
IL155841A0 (en) 2003-12-23
SK5822003A3 (en) 2004-06-08
CZ20031316A3 (cs) 2003-10-15
EP1337529A2 (fr) 2003-08-27
ATE337311T1 (de) 2006-09-15
FR2816618B1 (fr) 2002-12-27
DK1337529T3 (da) 2006-12-18
FR2816618A1 (fr) 2002-05-17
ZA200303794B (en) 2004-06-29
EA200300568A1 (ru) 2003-12-25
JP2004514661A (ja) 2004-05-20
CA2429311A1 (en) 2002-05-23
KR100849608B1 (ko) 2008-07-31
ES2271119T3 (es) 2007-04-16
WO2002040474A3 (fr) 2002-10-31
AU1836502A (en) 2002-05-27
HRP20030379A2 (en) 2005-04-30
BR0115312A (pt) 2003-09-23
NO20032187L (no) 2003-06-26
EE200300207A (et) 2003-08-15
PL363004A1 (en) 2004-11-15
DE60122567D1 (de) 2006-10-05
AR034006A1 (es) 2004-01-21
EP1695964A1 (fr) 2006-08-30
BG107793A (bg) 2004-08-31
PT1337529E (pt) 2006-12-29
WO2002040474A2 (fr) 2002-05-23
HUP0303758A2 (hu) 2004-03-01
KR20030060934A (ko) 2003-07-16
CN1483031A (zh) 2004-03-17
NO20032187D0 (no) 2003-05-14
YU46803A (sh) 2006-05-25
DE60122567T2 (de) 2007-08-23

Similar Documents

Publication Publication Date Title
HUP0303758A3 (en) Heterocyclylalkyl piperidine derivatives and their preparation and pharmaceutical compositions containing them
IL152718A0 (en) Piperidine derivatives and pharmaceutical compositions containing the same
IL151209A0 (en) Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparation
DZ3313A1 (fr) Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant
HUP0400636A3 (en) Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and preparation thereof
HUP0303835A3 (en) Anti-allergic piperidine compounds, their use and pharmaceutical compositions containing them
HUP0301391A3 (en) Piperazine and piperidine derivatives pharmaceutical compositions containing them and their use
HUP0302550A3 (en) Glucopyranosyloxypyrazole derivatives and use thereof in medicines and pharmaceutical compositions containing them
AU9025701A (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containingthe same
HUP0400837A3 (en) 2-phenyl-thiazole derivatives, their use and pharmaceutical compositions containing them
HUP0204283A3 (en) Piperidine quinolyl propyl derivatives, preparation method and pharmaceutical compositions containing same
HUP0204474A3 (en) 1h-imidazopyridine derivatives, pharmaceutical compositions containing them and their use
HUP0400551A2 (en) Piperazine derivatives, their preparation and pharmaceutical compositions containing them
HUP0300534A3 (en) Antitumoral ecteinascidin derivatives and pharmaceutical compositions containing them
HUP0301713A3 (en) Pharmaceutical compositions containing propenone derivatives and their use
IL151912A0 (en) Pyrolidine derivatives, their preparation and pharmaceutical compositions containing them
HUP0303184A3 (en) Substituted c-cyclohexylmethylamine derivatives and pharmaceutical compositions containing them
HUP0204354A3 (en) Novel heterocyclic derivatives, preparation method and pharmaceutical compositions containing same and their use
HUP0303673A3 (en) Piperidine derivatives and pharmaceutical compositions containing these derivatives as the active ingredient
HUP0303204A3 (en) 1-methylcarbapenem derivatives and pharmaceutical compositions containing them
IL159219A0 (en) Pyrrolidine oxadiazole derivatives, their preparation and pharmaceutical compositions containing them
IL151832A0 (en) Pharmaceutical compositions containing oligosaccharides and preparation thereof
AU4834101A (en) N-deacetylthiocolchicine derivatives and pharmaceutical compositions containing them
HUP0203383A3 (en) Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof
HUP0201443A3 (en) 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
GB9A Succession in title

Owner name: NOVEXEL, FR

Free format text: FORMER OWNER(S): AVENTIS PHARMA S.A., FR

FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished